Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions. Eur Urol. 2019;75(3):385–96.
Article
Google Scholar
Liang Z, Hu R, Yang Y, An N, Duo X, Liu Z, et al. Is dynamic contrast enhancement still necessary in multiparametric magnetic resonance for diagnosis of prostate cancer: a systematic review and meta-analysis. Transl Androl Urol. 2020;9(2):553–73.
Article
Google Scholar
Cho J, Ahn H, Hwang SIl, Lee HJ, Choe G, Byun SS, et al. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group. Prostate Int. 2020;8(4):146–51.
Article
Google Scholar
EL-Adalany MA, EL-Razek AAEL khalek A, EL-Diasty T, EL-Hendy A, EL-Metwally D. Comparison between biparametric and multiparametric MR imaging of Prostate Imaging Reporting and Data System Version 2.1 in detection of prostate cancer. Egypt J Radiol Nucl Med. 2021;52(1). https://doi.org/10.1186/s43055-021-00443-y.
Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L. Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis. Am J Roentgenol. 2019;212(2):357–65.
Article
Google Scholar
Xu L, Zhang G, Shi B, Liu Y, Zou T, Yan W, et al. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer. Cancer Imaging. 2019;19(1):1–8.
Article
Google Scholar
Franco FB, Fennessy FM. Arguments against using an abbreviated or biparametric prostate MRI protocol. Abdominal Radiol. 2020;45(12):3982–9.
Article
Google Scholar
van der Heide UA, Houweling AC, Groenendaal G, Beets-Tan RGH, Lambin P. Functional MRI for radiotherapy dose painting. Magn Reson Imaging. 2012;30(9):1216–23.
Article
Google Scholar
van der Heide UA, Korporaal JG, Groenendaal G, Franken S, van Vulpen M. Functional MRI for tumor delineation in prostate radiation therapy. Imaging Med. 2011;3(2):219–31.
Article
Google Scholar
Her EJ, Haworth A, Rowshanfarzad P, Ebert MA. Progress towards patient-specific, spatially-continuous radiobiological dose prescription and planning in prostate cancer IMRT: An overview. Cancers (Basel). 2020;12(4):854.
Article
CAS
Google Scholar
Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 2005;6(2):112–7.
Article
Google Scholar
Her EJ, Haworth A, Sun Y, Williams S, Reynolds HM, Kennedy A, et al. Biologically Targeted Radiation Therapy: Incorporating Patient-Specific Hypoxia Data Derived from Quantitative Magnetic Resonance Imaging. Cancers (Basel). 2021;13:4897.
Article
Google Scholar
Khalifa F, Soliman A, El-baz A, El-ghar MA, El-diasty T, Gimel G, et al. Models and methods for analyzing DCE-MRI: a review. Med Phys. 2014;41(12):124301.
Article
Google Scholar
Azahaf M, Haberley M, Betrouni N, Ernst O, Behal H, Duhamel A, et al. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer. J Magn Reson Imaging. 2016;43(3):737–49.
Article
Google Scholar
Ziayee F, Ullrich T, Blondin D, Irmer H, Arsov C, Antoch G, et al. Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnetic resonance imaging on prostate cancer detection. PLoS One. 2021;16(4 April 2021):1–12.
Google Scholar
Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, et al. Prostate cancer detection on dynamic contrast-enhanced MRI: Computer-aided diagnosis versus single perfusion parameter maps. Am J Roentgenol. 2011;197(5):1122–9.
Article
Google Scholar
Zhao J, Kader A, Mangarova DB, Brangsch J, Brenner W, Hamm B, et al. Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [68Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters. Cancers (Basel). 2021;13(1404):1–12.
Google Scholar
Isebaert S, de Keyzer F, Haustermans K, Lerut E, Roskams T, Roebben I, et al. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology. Eur J Radiol. 2012;81(3):e217–22.
Article
Google Scholar
Kim SH, Choi MS, Kim MJ, Kim YH, Cho SH. Role of semi–quantitative dynamic contrast–enhanced MR imaging in characterization and grading of prostate cancer. Eur J Radiol. 2017;94(June):154–9.
Article
Google Scholar
Vos EK, Litjens GJS, Kobus T, Hambrock T, Kaa C a H van de, Barentsz JO, et al. Assessment of Prostate Cancer Aggressiveness Using Dynamic Contrast-enhanced Magnetic Resonance Imaging at 3 T. Eur Urol. 2013;64(3):448–55.
Wei C, Jin B, Szewczyk-Bieda M, Gandy S, Lang S, Zhang Y, et al. Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterisation of prostate cancer. Oncotarget. 2018;9(22):15997–6007.
Article
Google Scholar
Afshari Mirak S, Mohammadian Bajgiran A, Sung K, Asvadi NH, Markovic D, Felker ER, et al. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2. Abdom Radiol. 2020;45(7):2225–34.
Article
Google Scholar
Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–57.
Article
Google Scholar
Dynamika. London, UK: Image Analysis Group; Available from: http://www.ia-grp.com
Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40(11):715–24.
Article
Google Scholar
Lu H, Clingman C, Golay X, van Zijl PCM. Determining the longitudinal relaxation time (T1) of blood at 3.0 tesla. Magn Reson Med. 2004;52(3):679–82.
Article
Google Scholar
de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC, de Bazelaire CMJ, Duhamel GD, et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology. 2004;230(3):652–9.
Article
Google Scholar
Weinmann HJ, Laniado M, Mützel W, Injection I, Healthy I. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR. 1984;16(2):167–72.
CAS
Google Scholar
Parker GJM, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, et al. Experimentally-Derived Functional Form for a Population-Averaged High-Temporal-Resolution Arterial Input Function for Dynamic Contrast-Enhanced MRI. Magn Reson Med. 2006;1000(October):993–1000.
Article
Google Scholar
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from DCE T1w MRI of a Diffusable Tracer: Standardized Quantities and Symbols. J Magn Reson Imaging. 1999;10:223–32.
Article
CAS
Google Scholar
Reynolds HM, Williams S, Zhang A, Chakravorty R, Rawlinson D, Ong CS, et al. Development of a registration framework to validate MRI with histology for prostate focal therapy. Med Phys. 2015;42(12):7078–89.
Article
CAS
Google Scholar
Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Routledge; 1988. p. 567.
Google Scholar
de Rooij M, Israël B, Bomers JGR, Schoots IG, Barentsz JO. Can Biparametric Prostate Magnetic Resonance Imaging Fulfill its PROMIS? Eur Urol. 2020;78(4):512–4.
Article
Google Scholar
American College of Radiology. PI-RADS Version 2.1. Prostate Imaging-Reporting and Data System. 2019. p. 1–69.
Google Scholar
Wu X, Reinikainen P, Kapanen M, Vierikko T, Ryymin P, Kellokumpu-Lehtinen PL. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI). Diagn Interv Imaging. 2019;100(11):699–708.
Article
CAS
Google Scholar
Low RN, Fuller DB, Muradyan N. Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy. Am J Roentgenol. 2011;197(4):907–15.
Article
Google Scholar
Ploussard G, Rouvière O, Rouprêt M, van den Bergh R, Renard-Penna R. The current role of MRI for guiding active surveillance in prostate cancer. Nat Rev Urol. 2022;19(6):357–65.
Dregely I, Prezzi D, Kelly-Morland C, Roccia E, Neji R, Goh V. Imaging biomarkers in oncology: Basics and application to MRI. J Magn Reson Imaging. 2018;48(1):13–26.
Article
Google Scholar
Sung YS, Park B, Choi Y, Lim HS, Woo DC, Kim KW, et al. Dynamic contrast-enhanced MRI for oncology drug development. J Magn Reson Imaging. 2016;44(2):251–64.
Article
Google Scholar
Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Dariya I, et al. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography. 2016;2(1):56–66.
Article
Google Scholar
Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, et al. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Part II Tomography. 2019;5(1):99–109.
Article
Google Scholar
Othman AE, Falkner F, Kessler DE, Martirosian P, Weiss J, Kruck S, et al. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance. Magn Reson Imaging. 2016;34(4):496–501.
Article
Google Scholar
Fritz-Hansen T, Rostrup E, Larsson HB, Søndergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med. 1996;36(2):225–31.
Article
CAS
Google Scholar
Sun Y, Reynolds HM, Parameswaran B, Wraith D, Finnegan ME, Williams S, Haworth A. Multiparametric MRI and radiomics in prostate cancer: a review. Australas Phys Eng Sci Med. 2019;42(1):3–25.
Raunig DL, Mcshane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, et al. Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Stat Methods Med Res. 2015;24(1):27–67.
Article
Google Scholar
Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, et al. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2019;49(7):e101–21.
Article
Google Scholar
Open Science Intitiative for Perfusion Imaging. Available from: https://osipi.org/. [Cited 2022 Mar 25].
Wang Y, Tadimalla S, Rai R, Goodwin J, Foster S, Liney G, et al. Quantitative MRI: Defining repeatability, reproducibility and accuracy for prostate cancer imaging biomarker development. Magn Reson Imaging. 2021;77:169–79.
Article
CAS
Google Scholar